SOHM, Inc. Sets Strategic Goals to Enter Biotechnology-Driven Cosmeceuticals Market
SOHM (OTC PINK:SHMN), a pharmaceutical and biotechnology company, has announced its strategic expansion into biotechnology-based cosmeceuticals. The company plans to leverage its biotech division to develop advanced skincare solutions incorporating biologically sourced actives such as exosomes, peptides, and regenerative proteins.
Under the guidance of Dr. Lucia Piccotti, SOHM's Cosmeceuticals expert and Health Advisory board member, the company will focus on cell culture and fermentation methods for producing high-purity cosmetic ingredients, along with advanced formulation strategies to enhance absorption, stability, and skin bioactivity. This initiative aligns with SOHM's strategic vision of expanding into high-value, innovation-focused product categories.
SOHM (OTC PINK:SHMN), un'azienda farmaceutica e biotecnologica, ha annunciato la sua espansione strategica nel settore dei cosmeceutici basati sulla biotecnologia. L'azienda intende sfruttare la sua divisione biotech per sviluppare soluzioni avanzate per la cura della pelle che integrano principi attivi di origine biologica come esosomi, peptidi e proteine rigenerative.
Sotto la guida della Dott.ssa Lucia Piccotti, esperta di cosmeceutici di SOHM e membro del consiglio consultivo sanitario, l'azienda si concentrerà su metodi di coltura cellulare e fermentazione per la produzione di ingredienti cosmetici ad alta purezza, insieme a strategie di formulazione avanzate per migliorare l'assorbimento, la stabilità e la bioattività cutanea. Questa iniziativa è in linea con la visione strategica di SOHM di espandersi in categorie di prodotti ad alto valore e orientati all'innovazione.
SOHM (OTC PINK:SHMN), una empresa farmacéutica y biotecnológica, ha anunciado su expansión estratégica hacia los cosmecéuticos basados en biotecnología. La compañía planea aprovechar su división biotecnológica para desarrollar soluciones avanzadas para el cuidado de la piel que incorporen activos de origen biológico como exosomas, péptidos y proteínas regenerativas.
Bajo la dirección de la Dra. Lucia Piccotti, experta en cosmecéuticos de SOHM y miembro del consejo asesor de salud, la empresa se enfocará en métodos de cultivo celular y fermentación para producir ingredientes cosméticos de alta pureza, junto con estrategias avanzadas de formulación para mejorar la absorción, estabilidad y bioactividad en la piel. Esta iniciativa se alinea con la visión estratégica de SOHM de expandirse hacia categorías de productos de alto valor y enfocados en la innovación.
SOHM (OTC PINK:SHMN)은 제약 및 생명공학 회사로서 생명공학 기반 코스메슈티컬 분야로의 전략적 확장을 발표했습니다. 회사는 바이오 기술 부서를 활용하여 엑소좀, 펩타이드, 재생 단백질 등 생물학적 원료를 포함한 첨단 스킨케어 솔루션을 개발할 계획입니다.
SOHM의 코스메슈티컬 전문가이자 건강 자문위원회 멤버인 루치아 피코티 박사의 지도 아래, 회사는 고순도 화장품 원료 생산을 위한 세포 배양 및 발효 방법과 흡수력, 안정성, 피부 생체 활성도를 향상시키는 고급 제형 전략에 집중할 예정입니다. 이 이니셔티브는 고부가가치 혁신 중심 제품 카테고리로 확장하겠다는 SOHM의 전략적 비전과 일치합니다.
SOHM (OTC PINK:SHMN), une entreprise pharmaceutique et biotechnologique, a annoncé son expansion stratégique dans les cosméceutiques à base de biotechnologie. La société prévoit d'exploiter sa division biotechnologique pour développer des solutions avancées de soins de la peau intégrant des actifs d'origine biologique tels que des exosomes, des peptides et des protéines régénératrices.
Sous la direction de la Dre Lucia Piccotti, experte en cosméceutiques chez SOHM et membre du conseil consultatif en santé, l'entreprise se concentrera sur les méthodes de culture cellulaire et de fermentation pour produire des ingrédients cosmétiques de haute pureté, ainsi que sur des stratégies de formulation avancées visant à améliorer l'absorption, la stabilité et la bioactivité cutanée. Cette initiative s'inscrit dans la vision stratégique de SOHM d'étendre son activité à des catégories de produits à forte valeur ajoutée et axées sur l'innovation.
SOHM (OTC PINK:SHMN), ein Pharma- und Biotechnologieunternehmen, hat seine strategische Expansion in biotechnologisch basierte Cosmeceuticals angekündigt. Das Unternehmen plant, seine Biotech-Abteilung zu nutzen, um fortschrittliche Hautpflege-Lösungen zu entwickeln, die biologisch gewonnene Wirkstoffe wie Exosomen, Peptide und regenerative Proteine enthalten.
Unter der Leitung von Dr. Lucia Piccotti, SOHMs Expertin für Cosmeceuticals und Mitglied des Gesundheitsbeirats, wird sich das Unternehmen auf Zellkultur- und Fermentationsmethoden zur Herstellung hochreiner kosmetischer Inhaltsstoffe konzentrieren, zusammen mit fortschrittlichen Formulierungsstrategien zur Verbesserung der Absorption, Stabilität und Hautbioaktivität. Diese Initiative entspricht der strategischen Vision von SOHM, in wertschöpfende, innovationsorientierte Produktkategorien zu expandieren.
- Strategic expansion into high-value biotechnology-based cosmeceuticals market
- Leveraging existing biotech division capabilities for new product development
- Focus on IP development and scientific credibility
- Potential for international market growth
- None.
CHINO HILLS, CALIFORNIA / ACCESS Newswire / June 24, 2025 / SOHM, Inc. (OTC PINK:SHMN), a leading pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, health and wellness solutions, proudly announces that it has established strategic goals to expand into the development of biotechnology-based cosmeceuticals as part of its long-term growth strategy.
This initiative represents a natural evolution of SOHM's historical product line, which has long emphasized wellness, skin health, and therapeutic-grade formulations. The company's investment in a dedicated biotech division now enables it to pursue advanced biologically inspired skincare technologies, including next-generation ingredients and delivery systems derived from modern bioprocessing platforms.
"We see biotechnology as a powerful tool to enhance the quality and performance of skin care," said Dr. Lucia Piccotti, our expert on Cosmeceuticals and personal Health Advisory board member of SOHM. "This strategic expansion builds directly on our legacy in health and wellness products while allowing us to lead in a new era of scientifically driven cosmeceuticals."
SOHM's biotech-driven cosmeceutical goals include exploration of:
Biologically sourced actives such as exosomes, peptides, and regenerative proteins
Cell culture and fermentation methods for producing high-purity cosmetic ingredients
Advanced formulation strategies to optimize absorption, stability, and skin bioactivity
The biotech cosmeceutical expansion aligns with SOHM's broader strategic vision of moving into high-value, innovation-focused product categories, with an emphasis on IP, scientific credibility, and international market growth.
"This is not a departure from who we are-it's the next step forward," added Dr. Lucia Piccotti, our expert on Cosmeceuticals and personal Health Advisory board member of SOHM. "With the support of our biotech division, we aim to develop a new class of premium skincare solutions that reflect both our heritage and our future."
Further updates will be provided as the company advances toward development milestones in this new product segment.
About SOHM, Inc.:
SOHM is a biopharmaceutical company dedicated to developing and commercializing gene editing technologies for research, synthetic biology, and therapeutic applications. With a focus on precision medicine, SOHM aims to revolutionize the treatment of genetic diseases by providing safe, efficient, and targeted solutions for gene editing. Through strategic collaborations and groundbreaking research, SOHM is at the forefront of advancing the field of gene therapy. SOHM strives to transform the landscape of genome editing and improve the quality of life through scientific discovery.
For further information regarding this announcement or to explore potential collaborations, please contact:
SOHM, Inc.:
Name: Baron Night, CEO/Dr. David Aguilar, COO
Email: info@sohm.com
Phone: (714) 522-6700
Safe Harbor Statement:
This news release contains "forward-looking statements," which are statements that are not purely historical and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development-stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report for the most recent fiscal year and our quarterly reports uploaded from time to time on OTCMarkets.com.
SOURCE: SOHM, Inc
View the original press release on ACCESS Newswire
FAQ
What is SOHM's (SHMN) new strategic expansion plan for 2025?
What technologies will SOHM (SHMN) use in its cosmeceuticals development?
Who is leading SOHM's (SHMN) cosmeceuticals initiative?
How does the cosmeceuticals expansion align with SOHM's (SHMN) overall strategy?
